Biohaven Therapeutics & Yale Univ. v. Avilar Therapeutics (D. Del. 2025)
(rights and duties under confidential disclosure agreement regarding evaluation for possible Investment in life sciences matter)
Category: Expert Witness History
Howmedica v. Howard (D.N.J. 2024)
(reasonableness of protection of trade secret matter)
BHI Energy v. KVP Holdings (N.D. Tx. 2023-24)
(addressing reasonableness of trade secrecy measures)
Clyde & Co. (Paris)
iXblue v. Safran (ICC N.Y. and Paris 2022) Addressing confidentiality practices in show-how transfer in a patent and trade secret field-of-use nonexclusive license
Daewoong Pharma (S. Korea)
In the matter of certain Botulinum Toxin Products (ITC Inv. 337-TA-1145 2021) Sponsored public interest submission to ITC criticizing ALJ’s ruling that claimant’s bacteria is a trade secret. ITC reversed ALJ ruling.
Harcus Parker (London)
Major Commodity Enterprise v. Media Company (High Court of Justice London 2020) (addressing interplay between trade secret owner’s property right and First Amendment rights of publisher in relation to a parallel action pending in the S.D.N.Y.)
Nobel Biocare
Bichacho et al v. Nobel Biocare Services AG (ICC Zurich 2018) (analysis of controlling principles for assessing U.S. patent damages in respect of independent and dependent claims)
Amerihua Produce
Blue Book Services v. Amerihua Produce (N.D. Ill. 2018) (analysis of secrecy safeguards in standard form of license agreement for data)
De Simone v. VSL Pharmaceuticals (D. Md. 2018) (custom and usage concerning duration of secrecy obligation)
Lowenstein Sandler
The Medicines Co. v. Biogen MA (D.N.J. 2017) (custom and usage as to correlation between terms of license grant and royalty provisions)